Back
Avidity Biosciences Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
39
RNA
Avidity Biosciences
Last Price:
46.69
Seasonality Move:
33.04%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Avidity Biosciences Price Quote
$46.69
-0.02 (-1.73%)
(Updated: November 9, 2024 at 5:44 AM ET)
Avidity Biosciences Key Stats
Sell
39
Avidity Biosciences (RNA)
is a Sell
Day range:
$44.85 - $47.30
52-week range:
$5.15 - $50.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
379.36
P/B ratio:
4.48%
Volume:
917.4K
Avg. volume:
875.1K
1-year change:
761.81%
Market cap:
$5.5B
Revenue:
$9.6M
EPS:
$-2.95
How Much Does Avidity Biosciences Make?
-
How Much Are Avidity Biosciences's Sales Annually?
RNA Revenues are $9.6M -
How Much Profit Does Avidity Biosciences's Make A Year?
RNA net income is -$212.2M
Is Avidity Biosciences Growing As A Company?
-
What Is Avidity Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.12% -
What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avidity Biosciences Stock Price Performance
-
Did Avidity Biosciences Stock Go Up Last Month?
Avidity Biosciences share price went up by 0.82% last month -
Did RNA's Share Price Rise Over The Last Year?
RNA share price rose by 761.81% over the past 1 year
What Is Avidity Biosciences 52-Week High & Low?
-
What Is Avidity Biosciences’s 52-Week High Share Price?
Avidity Biosciences has traded as high as $50.78 over the past 52 weeks -
What Is Avidity Biosciences’s 52-Week Low Share Price?
Avidity Biosciences has traded as low as $5.15 over the past 52 weeks
Avidity Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avidity Biosciences?
-
How Much Debt Does Avidity Biosciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avidity Biosciences Have?
Cash and short term investments quarterly total is $1.3B -
What Is Avidity Biosciences’s Book Value Per Share?
Book value per share is 11.17
Is Avidity Biosciences Cash Flow Positive?
-
What Is RNA Cash Flow From Operations?
Cash flow from operations (TTM) is -$155.7M -
What Is Avidity Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $868.1M -
What Is Avidity Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$288.1M
Avidity Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
RNA return on invested capital is -34.78% -
What Is Avidity Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -30.7% -
What Is RNA Return On Equity?
ROE is a measure of profitability and is -34.78%
Avidity Biosciences Earnings Date & Stock Price
-
What Is Avidity Biosciences's Stock Price Today?
A single share of RNA can be purchased today for 46.71 -
What Is Avidity Biosciences’s Stock Symbol?
Avidity Biosciences trades on the nasdaq under the ticker symbol: RNA -
When Is Avidity Biosciences’s Next Earnings Date?
The next quarterly earnings date for Avidity Biosciences is scheduled on February 28, 2025 -
When Is RNA's next ex-dividend date?
Avidity Biosciences's next ex-dividend date is November 10, 2024 -
How To Buy Avidity Biosciences Stock?
You can buy Avidity Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avidity Biosciences Competitors
-
Who Are Avidity Biosciences's Competitors?
Below is a list of companies who compete with Avidity Biosciences or are related in some way:
Avidity Biosciences Dividend Yield
-
What Is RNA Dividend Yield?
Avidity Biosciences’s dividend yield currently is 0% -
What Is Avidity Biosciences’s Payout Ratio?
Avidity Biosciences’s payout ratio is 0% -
When Did Avidity Biosciences Last Pay A Dividend?
The latest dividend pay date is November 10, 2024 -
What Is Avidity Biosciences’s Dividend Per Share?
Avidity Biosciences pays a dividend of $0.00 per share
Avidity Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.52% |
| Revenue: | -11.7% | -48.99% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 68.36 |
| Upside from Last Price: | 46.36% |